Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC-dependence in intrahepatic cholangiocarcinoma.
Supriya K Saha,John D Gordan,Benjamin P Kleinstiver,Phuong Vu,Mortada S Najem, Jia-Chi Yeo,Lei Shi,Yasutaka Kato,Rebecca S Levin,James T Webber,Leah J Damon,Regina K Egan,Patricia Greninger,Ultan McDermott,Mathew J Garnett,Roger L Jenkins,Kimberly M Rieger-Christ,Travis B Sullivan,Aram F Hezel,Andrew S Liss,Yusuke Mizukami,Lipika Goyal,Cristina R Ferrone,Andrew X Zhu,J Keith Joung,Kevan M Shokat,Cyril H Benes,Nabeel Bardeesy CANCER DISCOVERY（2016）
关键词
intrahepatic cholangiocarcinoma,isocitrate dehydrogenase,src dependence
AI 理解论文
溯源树
样例
